WellWell Medical strives to develop foresight and futuristic innovation. We believe that 3D Bio-Printing will be one such innovation to provide a novel way to treat for patients. We aim to partner such companies that offer best in class Bio-Printing solution in a variety of specialities. Our ultimate aim is to have the best and brightest R&D scientist to offer a real solution for different patient treatments.
Currently, bioprinting can be used to print tissues and organs to help research drugs and pills. There are various types of 3D deposition methods including, but not limited to, stereolithography, photolithography, selective laser sintering, fused deposition modeling, inkjet printing, pneumatic extrusion printing, electron beam melting, and laminated object manufacturing. Parameters that are important to consider when 3D printing include resolution, deposition speed, bioink compatibility, scalability, and its ease of use.
However, emerging innovations span from bioprinting of cells or extracellular matrix deposited into a 3D gel layer by layer to produce the desired tissue or organ. In addition, 3D bioprinting has begun to incorporate the printing of scaffolds. These scaffolds can be used to regenerate joints and ligaments.
We are collaborating across borders and industries to identify the parts most in need, validate the designs, and begin 3D printing them